Class II
Ongoing
Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.
This recall is currently active, issued January 14, 2026. It was issued by Specgx, Llc.
- Company
- Specgx, Llc
- Recall Initiated
- December 16, 2025
- Posted
- January 14, 2026
- Recall Number
- D-0254-2026
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 287,988 Bottles.
- Firm Location
- Webster Groves, MO, United States
- Official Source
- View on FDA website ↗
Reason for Recall
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
Distribution
Nationwide
Lot / Code Info
Lot: 0523J23904, expires: 05/2027; 0523J24426, 0523J24427, expires: 06/2027.
Other recent Class II Drug recalls
Vista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, L...
Wizcure Pharmaa Private Limited
· Mar 4, 2026
Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: Av...
Avkare
· Mar 4, 2026
Agebox iKids-Growth (Day Formula) capsules, 60-count bottles, Manufactured Exclusively For: AGEBOX I...
Agebox
· Mar 4, 2026
Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPL...
Leo Pharma Inc
· Mar 4, 2026
Pro Numb Tattoo Numbing Spray, For Sensitive Skin, 4% Lidocaine, [1FL OZ/28.4 ML or 4 oz/120 mL] per...
Pro Numb Tattoo Numbing Spray Llc
· Feb 18, 2026